216 related articles for article (PubMed ID: 17908965)
1. CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines.
Shao L; Cui Y; Li H; Liu Y; Zhao H; Wang Y; Zhang Y; Ng KM; Han W; Ma D; Tao Q
Clin Cancer Res; 2007 Oct; 13(19):5756-62. PubMed ID: 17908965
[TBL] [Abstract][Full Text] [Related]
2. CMTM5-v1 induces apoptosis in cervical carcinoma cells.
Shao L; Guo X; Plate M; Li T; Wang Y; Ma D; Han W
Biochem Biophys Res Commun; 2009 Feb; 379(4):866-71. PubMed ID: 19124004
[TBL] [Abstract][Full Text] [Related]
3. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
4. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
5. CMTM5 exhibits tumor suppressor activity through promoter methylation in oral squamous cell carcinoma.
Zhang H; Nan X; Li X; Chen Y; Zhang J; Sun L; Han W; Li T
Biochem Biophys Res Commun; 2014 May; 447(2):304-10. PubMed ID: 24721428
[TBL] [Abstract][Full Text] [Related]
6. CMTM5 induces apoptosis of pancreatic cancer cells and has synergistic effects with TNF-alpha.
Guo X; Li T; Wang Y; Shao L; Zhang Y; Ma D; Han W
Biochem Biophys Res Commun; 2009 Sep; 387(1):139-42. PubMed ID: 19577543
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia.
Niu J; Li H; Zhang Y; Li J; Xie M; Li L; Qin X; Qin Y; Guo X; Jiang Q; Liu Y; Chen S; Huang X; Han W; Ruan G
Leuk Res; 2011 Jun; 35(6):771-6. PubMed ID: 21168207
[TBL] [Abstract][Full Text] [Related]
8. The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
Ying J; Srivastava G; Hsieh WS; Gao Z; Murray P; Liao SK; Ambinder R; Tao Q
Clin Cancer Res; 2005 Sep; 11(18):6442-9. PubMed ID: 16166418
[TBL] [Abstract][Full Text] [Related]
9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
11. [Research advances in CKLF-like MARVEL transmembrane domain containing member 5].
Yuan YQ; Xiao YB; Liu ZH; Zhang XW; Xu T; Wang XF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):625-8. PubMed ID: 23286412
[TBL] [Abstract][Full Text] [Related]
12. Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
Ying J; Li H; Seng TJ; Langford C; Srivastava G; Tsao SW; Putti T; Murray P; Chan AT; Tao Q
Oncogene; 2006 Feb; 25(7):1070-80. PubMed ID: 16247458
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and histone modification regulate silencing of OPG during tumor progression.
Lu TY; Kao CF; Lin CT; Huang DY; Chiu CY; Huang YS; Wu HC
J Cell Biochem; 2009 Sep; 108(1):315-25. PubMed ID: 19565568
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas.
Lee KY; Geng H; Ng KM; Yu J; van Hasselt A; Cao Y; Zeng YX; Wong AH; Wang X; Ying J; Srivastava G; Lung ML; Wang LD; Kwok TT; Levi BZ; Chan AT; Sung JJ; Tao Q
Oncogene; 2008 Sep; 27(39):5267-76. PubMed ID: 18469857
[TBL] [Abstract][Full Text] [Related]
15. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
[TBL] [Abstract][Full Text] [Related]
16. IGSF4 promoter methylation and expression silencing in human cervical cancer.
Li J; Zhang Z; Bidder M; Funk MC; Nguyen L; Goodfellow PJ; Rader JS
Gynecol Oncol; 2005 Jan; 96(1):150-8. PubMed ID: 15589594
[TBL] [Abstract][Full Text] [Related]
17. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines.
Dowdy SC; Gostout BS; Shridhar V; Wu X; Smith DI; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Oct; 99(1):126-34. PubMed ID: 16023706
[TBL] [Abstract][Full Text] [Related]
18. ZIC1 is downregulated through promoter hypermethylation in gastric cancer.
Wang LJ; Jin HC; Wang X; Lam EK; Zhang JB; Liu X; Chan FK; Si JM; Sung JJ
Biochem Biophys Res Commun; 2009 Feb; 379(4):959-63. PubMed ID: 19135984
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
